Synkrino Biotherapeutics

Synkrino Biotherapeutics is a biotechnology platform that discovers and develops new drug targets directly from patients' immune systems. The platform provides life-threatening disease monitoring for pediatric rheumatologists. Currently, it is developing a rapid, portable on-site test for the RNA virus 2019-nCoV / COVID-19 to integrate with its existing community public health screening analysis program.Synkrino Biotherapeutics' therapies utilize the AI + Immune Discovery Engine (AIDE Engine), which applies neural networks and machine learning to measure patients' immune tissues for the repeated discovery of novel and biologically effective drug targets, enabling healthcare providers to cure patients and improve lives.